您的当前位置:首页 > 行业数据 > AK104-302研究显示卡度尼利单抗联合化疗在胃癌全人群获益
图片属性
图片格式:PNG 图片大小:961KB 图片尺寸:2303*1080
同报告图片
 / 4
AK104-302研究显示卡度尼利单抗联合化疗在胃癌全人群获益_第1页
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
AK104-302研究显示卡度尼利单抗联合化疗在胃癌全人群获益_第2页
AK104-302研究显示卡度尼利单抗联合化疗在胃癌全人群获益_第3页
AK104-302研究显示卡度尼利单抗联合化疗在胃癌全人群获益_第4页
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
AK104-302研究显示卡度尼利单抗联合化疗在胃癌全人群获益_第5页
fCDliIbmnJ8gfCDmlbDph48gfAp8IC0tLSB8IC0tLSB8CnwgSUlJ5pyfIHwgOTIgfAp8IEkvSUnmnJ8gfCA4NiB8CnwgSUnmnJ8gfCAyOTYgfAoK6LWE5paZ5p2l5rqQ77ya5Yy76I2v6a2U5pa577yM5Y2O56aP6K+B5Yi456CU56m25omA77yI5oiq6IezMjAyNOW5tDbmnIgyNeaXpe+8iQ==
所属报告: 康方生物-港股公司研究报告-肺癌大适应症先发优势占位IO 2.0的未来已来-240708(31页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠